Published in Biol Psychiatry on April 15, 2009
Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement (2011) 1.81
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Neuron density and serotonin receptor binding in prefrontal cortex in suicide. Int J Neuropsychopharmacol (2011) 0.97
Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression. Hum Brain Mapp (2010) 0.91
The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging. Psychiatry Res (2014) 0.83
Abnormal default-mode network homogeneity in first-episode, drug-naive major depressive disorder. PLoS One (2014) 0.83
Metabolic imaging of bilateral anterior capsulotomy in refractory obsessive compulsive disorder: an FDG PET study. J Cereb Blood Flow Metab (2013) 0.81
The relationship between the acute cerebral metabolic response to citalopram and chronic citalopram treatment outcome. Am J Geriatr Psychiatry (2011) 0.80
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients. Eur J Nucl Med Mol Imaging (2015) 0.80
Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression. Am J Geriatr Psychiatry (2011) 0.79
Serotonin modulation of cerebral glucose metabolism: sex and age effects. Synapse (2012) 0.78
Brain serotonergic circuitries. Dialogues Clin Neurosci (2010) 0.78
Functional neuroimaging in geriatric depression. Psychiatr Clin North Am (2011) 0.77
Diabetes-associated depression: the serotonergic system as a novel multifunctional target. Indian J Pharmacol (2015) 0.77
Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging. Int J Geriatr Psychiatry (2012) 0.76
Positron emission tomography molecular imaging in late-life depression. J Geriatr Psychiatry Neurol (2014) 0.76
Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM. Int J Neuropsychopharmacol (2015) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
A default mode of brain function. Proc Natl Acad Sci U S A (2001) 50.73
The assessment of anxiety states by rating. Br J Med Psychol (1959) 24.58
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess (1996) 16.96
The precuneus: a review of its functional anatomy and behavioural correlates. Brain (2006) 13.48
Geriatric Depression Scale. Psychopharmacol Bull (1988) 6.27
The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry (1965) 5.09
Unrest at rest: default activity and spontaneous network correlations. Neuroimage (2007) 4.62
Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull (2003) 4.08
Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry (2000) 4.03
Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am J Psychiatry (1996) 3.61
Cytology and functionally correlated circuits of human posterior cingulate areas. Neuroimage (2005) 2.67
Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry (2008) 2.53
Some observations on cortical inputs to the macaque monkey amygdala: an anterograde tracing study. J Comp Neurol (2002) 2.42
Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res (2003) 2.14
Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet (1969) 1.80
Persistence of neuropsychologic deficits in the remitted state of late-life depression. Am J Geriatr Psychiatry (2006) 1.77
Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry (1996) 1.72
Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. JAMA (2003) 1.67
Disability in geriatric depression. Am J Psychiatry (1996) 1.55
The citalopram challenge test in patients with major depression and in healthy controls. Psychiatry Res (1999) 1.45
Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology (1993) 1.44
Depressive state- and disease-related alterations in neural responses to affective and executive challenges in geriatric depression. Am J Psychiatry (2008) 1.42
Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry (1997) 1.37
Clinical and phenomenological comparisons of late-onset and early-onset depression. Am J Psychiatry (1995) 1.32
Psychiatric disorders and 15-month mortality in a community sample of older adults. Am J Public Health (1989) 1.29
Prefrontal and striatal activation during sequence learning in geriatric depression. Biol Psychiatry (2005) 1.20
Subjective memory complaints: objective neural markers in patients with Alzheimer's disease and major depressive disorder. Ann Neurol (2002) 1.10
Reproducibility of cerebral glucose metabolic measurements in resting human subjects. J Cereb Blood Flow Metab (1988) 1.09
Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. Am J Psychiatry (1999) 1.08
Topographical and laminar distribution of cortical input to the monkey entorhinal cortex. J Anat (2007) 1.07
Translational research in late-life mood disorders: implications for future intervention and prevention research. Neuropsychopharmacology (2007) 1.04
A comparison of neurocognitive impairment in younger and older adults with major depression. Psychol Med (2008) 1.03
Hippocampal and anterior cingulate activation deficits in patients with geriatric depression. Am J Psychiatry (2001) 1.00
Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression. Am J Geriatr Psychiatry (2002) 0.99
Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patients. Am J Psychiatry (1998) 0.98
Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression. J Affect Disord (2007) 0.97
Glucose metabolic response to total sleep deprivation, recovery sleep, and acute antidepressant treatment as functional neuroanatomic correlates of treatment outcome in geriatric depression. Am J Geriatr Psychiatry (2002) 0.97
Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Neuropharmacology (1997) 0.96
Event-related potentials in an emotional go/no-go task and remission of geriatric depression. Neuroreport (2007) 0.94
The role of posterior parietal cortex in visually guided reaching movements in humans. Exp Brain Res (1997) 0.93
Serotonin modulation of cerebral glucose metabolism in normal aging. Neurobiol Aging (2004) 0.93
Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls. J Cereb Blood Flow Metab (2008) 0.93
Ventromedial prefrontal cortex processing during emotional evaluation in late-life depression: a longitudinal functional magnetic resonance imaging study. Biol Psychiatry (2008) 0.93
Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex. Pol J Pharmacol (2001) 0.90
Treatment of 70(+)-year-olds with recurrent major depression. Excellent short-term but brittle long-term response. Am J Geriatr Psychiatry (1999) 0.89
Selective serotonin reuptake inhibitors and neuroendocrine function. Life Sci (1999) 0.89
Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects. Synapse (2002) 0.86
The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience (1993) 0.85
Regional brain responses to serotonin in major depressive disorder. J Affect Disord (2004) 0.85
Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated. Neuropharmacology (2000) 0.81
Applications of neuroreceptor imaging to psychiatry research. Psychopharmacol Bull (2003) 0.80
Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography. Synapse (2009) 0.80
PET study of human voluntary saccadic eye movements in darkness: effect of task repetition on the activation pattern. Eur J Neurosci (1998) 0.79
Serotonergic modulation of hippocampal acetylcholine release after long-term neuronal grafting. Neuroreport (2000) 0.77
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet (2007) 7.01
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol (2006) 5.49
Network modulation in the treatment of Parkinson's disease. Brain (2006) 2.52
Changes in network activity with the progression of Parkinson's disease. Brain (2007) 2.46
Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab (2006) 2.42
Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci (2009) 2.01
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.98
Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage (2006) 1.92
Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage (2006) 1.84
A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput (2005) 1.78
Differential cortical and subcortical activations in learning rotations and gains for reaching: a PET study. J Neurophysiol (2003) 1.71
Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann Neurol (2003) 1.63
Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci (2008) 1.56
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol (2010) 1.56
The differential effect of PD and normal aging on early explicit sequence learning. Neurology (2003) 1.52
Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci (2010) 1.50
Learning and consolidation of visuo-motor adaptation in Parkinson's disease. Parkinsonism Relat Disord (2008) 1.44
Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues. Neuroimage (2010) 1.43
Using imaging to identify psychogenic parkinsonism before deep brain stimulation surgery. Report of 2 cases. J Neurosurg (2011) 1.43
Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol (2007) 1.42
FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage (2005) 1.40
Abnormal metabolic networks in atypical parkinsonism. Mov Disord (2008) 1.39
Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol (2002) 1.39
Microstructural white matter changes in primary torsion dystonia. Mov Disord (2008) 1.38
Preclinical Huntington's disease: compensatory brain responses during learning. Ann Neurol (2006) 1.36
Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects. Neuroimage (2010) 1.36
Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage (2009) 1.36
Primary dystonia: is abnormal functional brain architecture linked to genotype? Ann Neurol (2002) 1.35
Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging. Neurobiol Dis (2010) 1.34
Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice. Proc Natl Acad Sci U S A (2011) 1.33
Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study. Brain (2007) 1.33
Metabolic brain networks in translational neurology: concepts and applications. Ann Neurol (2012) 1.32
Quantitative Brain PET. Comparison of 2D and 3D Acquisitions on the GE Advance Scanner. Clin Positron Imaging (1998) 1.31
Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach. J Nucl Med (2002) 1.31
Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization. Mov Disord (2010) 1.31
Imaging essential tremor. Mov Disord (2010) 1.27
Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum Brain Mapp (2004) 1.26
Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism. J Cereb Blood Flow Metab (2006) 1.26
Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery (2004) 1.26
Microstructural white matter changes in carriers of the DYT1 gene mutation. Ann Neurol (2004) 1.24
Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. Brain (2008) 1.24
Quantification of Parkinson's disease-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging (2006) 1.24
Learning networks in health and Parkinson's disease: reproducibility and treatment effects. Hum Brain Mapp (2003) 1.23
Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology (2004) 1.21
Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism. Neuroimage (2004) 1.21
Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. J Nucl Med (2009) 1.20
Neuroimaging and therapeutics in movement disorders. NeuroRx (2005) 1.17
Increased sensorimotor network activity in DYT1 dystonia: a functional imaging study. Brain (2010) 1.16
The metabolic topography of posthypoxic myoclonus. Neurology (2004) 1.16
The functional neuroanatomy of geriatric depression. Int J Geriatr Psychiatry (2009) 1.16
An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. J Clin Exp Neuropsychol (2006) 1.15
Functional brain networks and abnormal connectivity in the movement disorders. Neuroimage (2011) 1.15
Dopaminergic suppression of brain deactivation responses during sequence learning. J Neurosci (2008) 1.15
The metabolic pathology of dopa-responsive dystonia. Ann Neurol (2005) 1.14
Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI. J Cereb Blood Flow Metab (2010) 1.14
Abnormal regional brain function in Parkinson's disease: truth or fiction? Neuroimage (2008) 1.12
Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord (2002) 1.12